Strengthening Trade and Health Governance Capacities to Address Non-Communicable Diseases in Asia: Challenges and Ways Forward
Strengthening Trade and Health Governance Capacities to Address Non-Communicable Diseases in Asia: Challenges and Ways Forward
复制标题
DOI：
10.1002/app5.91
复制
发表时间：
2015-05-01
影响因子：
1.9
通讯作者：
Walls, Helen
中科院分区：
文献类型：
--
作者：
Baker, Phillip;Kay, Adrian;Walls, Helen
贸易自由化是亚洲非传染性疾病负担日益加重的一个驱动因素，因为它在促进该地区烟草、酒精和超加工食品行业增长的同时，也限制了政府制定公共卫生法规的能力。这突出表明，该区域的卫生和贸易政策需要更加协调一致。然而，很少有关于亚洲的分析。在加强贸易和卫生政策的一致性和加强治理能力方面有哪些障碍和机会？如何将卫生，特别是通过遏制风险商品市场来预防非传染性疾病置于贸易政策的中心位置？我们借鉴了各种文献，概述了在管理亚洲与风险商品和非传染性疾病有关的卫生贸易关系方面的七个主要挑战，并提出了加强能力的建议。
Trade liberalisation is a driver of the rising burden of non-communicable diseases in Asia through its role in facilitating the growth of the region's tobacco, alcohol and ultra-processed foods industries while simultaneously restricting the capacities of governments to enact public health regulations. This highlights the need for greater coherence between health and trade policy in the region. Yet there has been little analysis of these topics with regard to Asia. What are the barriers and opportunities for enhancing trade and health policy coherence and strengthening governance capacities? How can health, in particular the prevention of non-communicable diseases through curbing risk commodity markets, be positioned more centrally in trade policy? We draw upon a diversity of literature to outline seven key challenges to governing the healthtrade nexus as it relates to risk commodities and non-communicable diseases in Asia, and offer suggestions for strengthening capacities.